Literature DB >> 12525604

Vigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland.

Victoria J Cavanaugh1, Yuping Deng, Mark P Birkenbach, Jacquelyn S Slater, Ann E Campbell.   

Abstract

To better understand the immunological mechanisms that permit prolonged shedding of murine cytomegalovirus (MCMV) from the salivary gland, the phenotypic and functional characteristics of leukocytes infiltrating the submaxillary gland (SMG) were analyzed in infected BALB/c mice. A robust innate immune response, comprised of CD11c+ major histocompatibility complex class II+ CD11b- CD8alpha+ dendritic cells and gamma/delta T-cell receptor-bearing CD3+ T cells was prominent through at least 28 days postinfection. Concurrently, a dramatic increase in pan-NK (DX5+) CD3+ and CD8+ T cells was observed, while CD4+ T cells, known to be essential for viral clearance from this tissue, increased slightly. The expression particularly of gamma interferon but also of interleukin-10 and CC chemokines was extraordinarily high in the SMG in response to MCMV infection. The gamma interferon was produced primarily by CD4+ and CD8+ T lymphocytes and DX5+ CD3+ T cells. The SMG CD8+ T cells were highly cytolytic ex vivo, and a significant proportion of these cells were specific to an immunodominant MCMV peptide. These peptide-specific clones were not exhausted by the presence of high virus titers, which persisted in the SMG despite the strength of the cell-mediated responses. In contrast, MCMV replication was efficiently cleared from the draining cervical and periglandular lymph nodes, a tissue displaying a substantially weaker antiviral response. Our data indicated that vigorous innate and acquired immune responses are elicited, activated, and retained in response to mucosal inflammation from persistent MCMV infection of the submaxillary gland.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525604      PMCID: PMC140858          DOI: 10.1128/jvi.77.3.1703-1717.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8(+) T cells.

Authors:  Christopher W McMahon; Allan J Zajac; Amanda M Jamieson; Laura Corral; Gianna E Hammer; Rafi Ahmed; David H Raulet
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

2.  Control of murine cytomegalovirus in the lungs: relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates.

Authors:  R Holtappels; J Podlech; G Geginat; H P Steffens; D Thomas; M J Reddehase
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

Review 3.  Control of infections by NK cells.

Authors:  C H Tay; E Szomolanyi-Tsuda; R M Welsh
Journal:  Curr Top Microbiol Immunol       Date:  1998       Impact factor: 4.291

4.  Cutting edge: inhibitory functions of the killer cell lectin-like receptor G1 molecule during the activation of mouse NK cells.

Authors:  Scott H Robbins; Khuong B Nguyen; Nobuaki Takahashi; Toshifumi Mikayama; Christine A Biron; Laurent Brossay
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

5.  Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells.

Authors:  C H Tay; R M Welsh
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

6.  Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells.

Authors:  Magdalena Moutaftsi; Anja M Mehl; Leszek K Borysiewicz; Zsuzsanna Tabi
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

7.  NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus.

Authors:  Teresa R Johnson; Seokmann Hong; Luc Van Kaer; Yasuhiko Koezuka; Barney S Graham
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

8.  MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo.

Authors:  Astrid Krmpotić; Dirk H Busch; Ivan Bubić; Friedemann Gebhardt; Hartmut Hengel; Milena Hasan; Anthony A Scalzo; Ulrich H Koszinowski; Stipan Jonjić
Journal:  Nat Immunol       Date:  2002-05-20       Impact factor: 25.606

9.  Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant.

Authors:  M R MacDonald; X Y Li; R M Stenberg; A E Campbell; H W Virgin
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

10.  Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways.

Authors:  T P Salazar-Mather; J S Orange; C A Biron
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

View more
  35 in total

1.  Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential.

Authors:  Michael Zasloff; A Paige Adams; Bernard Beckerman; Ann Campbell; Ziying Han; Erik Luijten; Isaura Meza; Justin Julander; Abhijit Mishra; Wei Qu; John M Taylor; Scott C Weaver; Gerard C L Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4⁺ and CD8⁺ T-cell immunity.

Authors:  Jason P Twohig; Morgan Marsden; Simone M Cuff; John R Ferdinand; Awen M Gallimore; William V Perks; Aymen Al-Shamkhani; Ian R Humphreys; Eddie C Y Wang
Journal:  FASEB J       Date:  2012-05-16       Impact factor: 5.191

Review 3.  Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response.

Authors:  A Reschner; P Hubert; P Delvenne; J Boniver; N Jacobs
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330

Review 4.  Animal models in autoimmune diseases: lessons learned from mouse models for Sjögren's syndrome.

Authors:  Byung Ha Lee; Adrienne E Gauna; Kaleb M Pauley; Yun-Jong Park; Seunghee Cha
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

5.  Murine cytomegalovirus interference with antigen presentation contributes to the inability of CD8 T cells to control virus in the salivary gland.

Authors:  Xiuju Lu; Amelia K Pinto; Ann M Kelly; Kathy S Cho; Ann B Hill
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 6.  Immunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus model.

Authors:  Irena Slavuljica; Daria Kveštak; Peter Csaba Huszthy; Kate Kosmac; William J Britt; Stipan Jonjić
Journal:  Cell Mol Immunol       Date:  2014-07-21       Impact factor: 11.530

7.  Natural killer cells regulate murine cytomegalovirus-induced sialadenitis and salivary gland disease.

Authors:  Virginia A Carroll; Alyssa Lundgren; Hairong Wei; Susan Sainz; Kenneth S Tung; Michael G Brown
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

8.  Innate immunity defines the capacity of antiviral T cells to limit persistent infection.

Authors:  Daniel M Andrews; Marie J Estcourt; Christopher E Andoniou; Matthew E Wikstrom; Andrea Khong; Valentina Voigt; Peter Fleming; Hyacinth Tabarias; Geoffrey R Hill; Robbert G van der Most; Anthony A Scalzo; Mark J Smyth; Mariapia A Degli-Esposti
Journal:  J Exp Med       Date:  2010-05-31       Impact factor: 14.307

Review 9.  Immunobiology of human cytomegalovirus: from bench to bedside.

Authors:  Tania Crough; Rajiv Khanna
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

10.  CD28/B7-mediated co-stimulation is critical for early control of murine cytomegalovirus infection.

Authors:  Charles H Cook; Li Chen; Jin Wen; Peter Zimmerman; Yingxue Zhang; Joanne Trgovcich; Yang Liu; Jian-Xin Gao
Journal:  Viral Immunol       Date:  2009-04       Impact factor: 2.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.